Bioinequivalence of Four 100mg Oral Aspirin Formulations in Healthy Volunteers
暂无分享,去创建一个
[1] J. Vial,et al. Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin. , 1990, Australian and New Zealand journal of medicine.
[2] F. Bochner,et al. The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. , 1990, Thrombosis research.
[3] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[4] G. FitzGerald,et al. Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. , 1988, Thrombosis research.
[5] J. Miners,et al. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. , 1986, British journal of clinical pharmacology.
[6] P. Ho,et al. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. , 1985, British Journal of Clinical Pharmacology.
[7] B. Weksler,et al. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. , 1985, Circulation.
[8] G. FitzGerald,et al. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. , 1984, The New England journal of medicine.
[9] S. Heptinstall,et al. DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS , 1981, The Lancet.
[10] C. Stoddard,et al. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. , 1981, The New England journal of medicine.
[11] R. Nelson,et al. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. , 1980, The New England journal of medicine.
[12] P. Majerus,et al. Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[13] John G. Wagner,et al. Fundamentals of Clinical Pharmacokinetics , 1975 .
[14] R. Menguy,et al. Evidence for a Sex-linked Difference in Aspirin Metabolism , 1972, Nature.
[15] G. Levy,et al. Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man , 1972, Clinical pharmacology and therapeutics.
[16] M. Rowland,et al. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. , 1972, Journal of pharmaceutical sciences.
[17] F. Bochner,et al. Determination of plasma aspirin and salicylic acid concentrations after low aspirin doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detection. , 1987, Journal of chromatography.
[18] F. Bochner,et al. Measurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assay. , 1980, Therapeutic drug monitoring.
[19] M. Gibaldi. Biopharmaceutics and clinical pharmacokinetics , 1977 .